ArticleNature2022
Reboot biomedical R&D in the global public interest.
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Increasing access to CAR-T therapy: a case study of an academic hospital's alternative innovation model.Orphanet journal of rare diseases · 2026Article
- The COVID-19 pandemic and access to vaccines in Latin America and the Caribbean: strategies adopted by the WHO and PAHOPandemia de COVID-19 e acesso a vacinas na América Latina e Caribe: estratégias da OMS e da OPAS.Cadernos de saude publica · 2026Article
- Article
- Reigniting the institutional engine for pharmaceutical access: when policy experiments become new global evidence.Frontiers in public health · 2026Article
- Six Sigma research in healthcare is associated with global health, research and development indicators: A scientometrics study based on countries by income groups.Anales del sistema sanitario de Navarra · 2025Article
- Article
- Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change.Journal of pharmaceutical policy and practice · 2025Article
- Global Trends and Evidence Gaps in Medical Errors Research: A Mixed-Methods Scientometrics Study.Journal of multidisciplinary healthcare · 2025Article
- Life Science 2.0: reframing the life science sector for 'the benefit on mankind'.Global health action · 2024Article
- The priority review voucher: a misconceived quid pro quo.BMJ global health · 2024Article
- Why are our medicines so expensive? Spoiler: Not for the reasons you are being told….The European journal of general practice · 2024Article
- Nucleoside Analogues for Chagas Disease and Leishmaniasis Therapy: Current Status and Future Perspectives.Molecules (Basel, Switzerland) · 2024Review
- Advancing global antibiotic research, development and access.Nature medicine · 2024Review
- An mRNA technology transfer programme and economic sustainability in health care.Bulletin of the World Health Organization · 2024Article
- Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.Globalization and health · 2024Article
- Addressing the Research and Development Gaps in Modern Phage Therapy.PHAGE (New Rochelle, N.Y.) · 2024Review
- Contracts and intellectual property rights in translational R&D: furthering safeguards in the public interest.Nature biotechnology · 2024Article
- Shaping the future of global access to safe, effective, appropriate and quality health products.BMJ global health · 2024Article
- Tracking global resources and capacity for health research: time to reassess strategies and investment decisions.Health research policy and systems · 2023Article
- The Virchow Prize: cementing commodification, coloniality and biomedical reductionism in global health?BMJ global health · 2023Article
Corrections and comments
- Commented on by
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35140380What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.